JANET BURNS: Open Payments
NPI 1780285569 · BROOKFIELD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,306 in 60 payments from 13 companies in 2025. Trend: 2023 $2,436 · 2024 $2,358 · 2025 $2,306
Food & beverage: $2,300Education: $5
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $723 |
| Teva Pharmaceuticals USA, Inc. | 6 | $419 |
| Otsuka America Pharmaceutical, Inc. | 6 | $227 |
| Neurocrine BioSciences, Inc. | 4 | $163 |
| Janssen Pharmaceuticals, Inc | 6 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $158 |
| ABBVIE INC. | 6 | $113 |
| Alkermes, Inc. | 4 | $108 |
| Lundbeck LLC | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
Products named: Auvelity, UZEDY, INGREZZA, AUSTEDO XR, CAPLYTA, ABILIFY MAINTENA, SPRAVATO, VRAYLAR.
Industry payments across WI — which companies pay providers there.
